Arlene B. Chapman

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2012 · 1.6K citations · Full text

Medicine, Nephrology, Pharmacology +14

Volume Progression in Polycystic Kidney Disease

Jared J. Grantham, Vicente E. Torres, Arlene B. Chapman et al. · New England Journal of Medicine · 2006 · 792 citations · Full text

Medicine, Nephrology, Radiology +16

Imaging Classification of Autosomal Dominant Polycystic Kidney Disease

María V. Irazabal, Laureano J. Rangel, Eric J. Bergstralh et al. · Journal of the American Society of Nephrology · 2014 · 616 citations · Full text

Medicine, Nephrology, Radiology +15

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2017 · 614 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Arlene B. Chapman, Olivier Devuyst, Kai‐Uwe Eckardt et al. · Kidney International · 2015 · 605 citations · Full text

Medicine, Molecular Medicine, Nephrology +15